Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1957 Jun;12(2):189–193. doi: 10.1111/j.1476-5381.1957.tb00119.x

Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice

J K A Beverley, B A Fry
PMCID: PMC1509667  PMID: 13446372

Abstract

Sulphadimidine, dapsone, and pyrimethamine have been tested alone and in various combinations for their therapeutic effect against toxoplasma infection in mice. In the treatment of active infection, sulphadimidine by itself was effective, but relapses were common. Pyrimethamine gave complete cures and prevented the carrier state when used in doses near to the toxic level. Dapsone alone was not as good as either of the other two drugs tested. The best combination was found to be sulphadimidine and pyrimethamine, which were synergic. In doses well below the toxic level, this combination not only controlled the acute infection but also prevented relapses and the development of the carrier state. Dapsone and pyrimethamine were also synergic, but were not as effective as the previous combination. No synergy was found between dapsone and sulphadimidine. The mechanism of relapse and the development of the carrier state and the modes of action of the drugs alone and in combination are discussed.

Full text

PDF
193

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CROSS J. B. Diasone and promin as therapeutic agents in experimental toxoplasmosis. Proc Soc Exp Biol Med. 1951 Mar;76(3):548–551. doi: 10.3181/00379727-76-18552. [DOI] [PubMed] [Google Scholar]
  2. EYLES D. E., COLEMAN N. Tests of 2,4-diaminopyrimidines on toxoplasmosis. Public Health Rep. 1952 Mar;67(3):249–252. [PMC free article] [PubMed] [Google Scholar]
  3. FRANCIS J., SPINKS A. Antibacterial action and metabolism of five sulphones. Br J Pharmacol Chemother. 1950 Dec;5(4):565–583. doi: 10.1111/j.1476-5381.1950.tb00608.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HITCHINGS G. H. Daraprim as an antagonist of folic and folinic acids. Trans R Soc Trop Med Hyg. 1952 Sep;46(5):467-73; discussion, 498-508. doi: 10.1016/0035-9203(52)90038-2. [DOI] [PubMed] [Google Scholar]
  5. SCHMIDT L. H., HUGHES H. B., SCHMIDT I. G. The pharmacological properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim. J Pharmacol Exp Ther. 1953 Jan;107(1):92–130. [PubMed] [Google Scholar]
  6. SUMMERS W. A. The effects of oral administration of aureomycin, sulfathiazole, sulfamerazine and 4,4'-diamino diphenyl sulfone on toxoplasmosis in mice. Am J Trop Med Hyg. 1949 Nov;29(6):889–893. doi: 10.4269/ajtmh.1949.s1-29.889. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES